A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice
Clinical trial NCT04963725 · COMPLETED
Trial details
- NCT number
- NCT04963725
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-18
- Primary completion
- 2022-12-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.